Notably, IBD dysregulated TJ protein expression is observed, characterized by downregulation of occludin and ZO-1 and upregulation of claudin-2, which correlates with disease progression and impaired mucosal healing [9]. The gene discussed is CLDN2; the disease is inflammatory bowel disease.